Trademark Overview
On Thursday, October 10, 2024, a trademark application was filed for NEXCIA with the United States Patent and Trademark Office. The USPTO has given the NEXCIA trademark a serial number of 98795155. The federal status of this trademark filing is EXAMINERS AMENDMENT - MAILED as of Tuesday, September 9, 2025. This trademark is owned by Ashley Diana Black International Holdings, LLC. The NEXCIA trademark is filed in the Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Cosmetic body care services, namely, cosmetic laser treatment of skin, laser resurfacing being providing laser skin enhancement procedures, laser skin rejuvenating services, and scar tissue reduction being scar revision services; medical services, namely, medical care in the field of tissue contouring, sculpting, and restructuring fat reduction, field of cellulite appearance reduction, field of blood flow stimulation, field of increasing circulation, and field of pre- and post-surgical tissue treatments
Medical apparatus used to stimulate blood flow through tissue at treatment site; medical apparatus that uses infrared radiation energy waves and other thermal sources to heat treatment site of patient; medical apparatus used to increase blood flow; medical apparatus with radio frequency functionality used in aiding the injury healing process; medical apparatus to stimulate tissue repair used for non-invasive and contactless treatments; medical apparatus used to remodel, rejuvenate, and revitalize collagen and fascia tissue, and used to reduce fat and cellulite; post-surgery medical device used to exercise skin around surgical site to create blood flow and reduce inflammation to shorten time for healing process; medical devices, namely, devices for stimulating pre-surgical treatment area and post-surgical treatment area; medical apparatus for cosmetically treating tissue, increasing circulation, and activating glands that produce stem cells; medical post-treatment devices used to reduce...
Providing online, non-downloadable software that monitors patient treatment sites, performs treatment site analysis of fascia tissue, and performs treatment site analysis of fascia tissue improvement over the complete treatment plan, and monitors cellulite and improvement thereof; providing online non-downloadable software that controls a medical device in performing modalities; software as a service (SAAS) services featuring software that monitors patient treatment sites, performs treatment site analysis of fascia tissue, and performs treatment site analysis of fascia tissue improvement over the complete treatment plan, and monitors cellulite and improvement thereof; software as a service (SAAS) services featuring software that controls a medical device in performing modalities; providing online non-downloadable software for processing data that supports treatment plans for treating fascia tissue